Ciprofloxacin HCl Industry in Global and Chinese Forecast to 2019 now...
LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Ciprofloxacin HCl Industry, 2009-2019” to its store. Inquire Before Buying on this report at...(PRWeb September 03, 2014)Read the full story at http://www.prweb.com/releases/-ciprofloxacin-hcl/industry-2009-2019/prweb12140170.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 4, 2014 Category: Pharmaceuticals Source Type: news
Aradigm doses first patient in Phase III trial of Pulmaquin
US-based pharmaceutical firm Aradigm has started dosing patients in the ORBIT-4 Phase III clinical trial of its proprietary formulation of inhaled ciprofloxacin (Pulmaquin) to treat non-cystic fibrosis bronchiectasis (non-CF BE). (Source: Drug Development Technology)
Source: Drug Development Technology - June 23, 2014 Category: Pharmaceuticals Source Type: news
Lupin launches generic Ciprofloxacin in US market
The company had earlier received final approval for the product from the United States Food and Drug Administration (USFDA), it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 13, 2014 Category: Pharmaceuticals Source Type: news
ciprofloxacin ophthalmic solution (Ciloxan)
Title: ciprofloxacin ophthalmic solution (Ciloxan)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 5/20/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 20, 2014 Category: Drugs & Pharmacology Source Type: news
Aradigm begins dosing in Phase III trial of pulmaquin to treat non-cystic fibrosis bronchiectasis
US-based pharmaceutical firm Aradigm has dosed first patient in the ORBIT-3 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) Phase III clinical trial of its proprietary formulation of inhaled ciprofloxacin (Pulmaquin) to treat non-cystic … (Source: Drug Development Technology)
Source: Drug Development Technology - May 2, 2014 Category: Pharmaceuticals Source Type: news
FDA grants orphan drug status to Bayer's bronchiectasis medicine Ciprofloxacin DPI
The US Food and Drug Administration (FDA) has granted orphan drug designation for Bayer HealthCare's investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) to treat patients with non-cystic fibrosis bronchiectasis (NCFB). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 24, 2014 Category: Pharmaceuticals Source Type: news
Lupin gets USFDA nod to market generic version of Cipro
Lupin said it has received US health regulator USFDA'S approval to market a generic version of Bayer's Cipro, used to treat infections, in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 6, 2014 Category: Pharmaceuticals Source Type: news
Study finds no increased risk of retinal detachment with use of certain antibiotics
In contrast to findings of a recent study, researchers in Denmark did not find an association between use of a class of antibiotics known as fluoroquinolones (such as ciprofloxacin) and an increased risk of retinal detachment, according to a study appearing in JAMA. Retinal detachment (a separation of the retina from its connection at the back of the eye) is an acute eye disorder that may lead to loss of vision despite prompt surgical intervention. A recent study found that use of fluoroquinolones was strongly associated with retinal detachment, reporting a 4. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 3, 2013 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news
Study Clears Certain Antibiotics of Serious Eye Risk
Cipro and similar drugs are unlikely to cause retinal detachment, researchers find
Source: HealthDay
Related MedlinePlus Pages: Antibiotics, Drug Safety, Retinal Detachment (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 26, 2013 Category: Consumer Health News Source Type: news
ciprofloxacin, Cipro, Cipro XR, Proquin XR
Title: ciprofloxacin, Cipro, Cipro XR, Proquin XRCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/9/2013 12:00:00 AM (Source: MedicineNet Hepatitis C General)
Source: MedicineNet Hepatitis C General - October 9, 2013 Category: Infectious Diseases Source Type: news
Ciprofloxacin Prophylaxis in High Risk Neutropenic PatientsCiprofloxacin Prophylaxis in High Risk Neutropenic Patients
Quinolones are often used as prophylaxis in high risk neutropenic patients, but resistance is increasing in the hospital units. BMC Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2013 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
Isolation of Advenella kashmirensis from a Diabetic Foot Wound
We describe the first case of human infection caused by Advenella kashmirensis. The patient had a history of diabetes mellitus type 2 and presented with a diabetic ulcer on the top of the big toe of the left foot. On the basis of the clinical presentation of the toe ulcer, the histologic appearance of tissue obtained at biopsy, and the microbiological culture results, the patient was diagnosed with a wound infection caused by A. kashmirensis. The patient experienced a favorable outcome following 42 days of oral ciprofloxacin therapy. The patient most likely acquired his infection from an environmental source, because A. ka...
Source: Clinical Microbiology Newsletter - September 15, 2013 Category: Microbiology Authors: Wim Maurissen, Joris Meeuwissen, Kevin Martens, Jozef Tits, Els Oris, Jan Verhaegen, Guy Coppens Source Type: news
Otonomy reports positive Phase Ib data of OTO-201 in children undergoing ear tube placement surgery
Clinical stage biopharmaceutical company Otonomy has reported positive data from a Phase Ib study of OTO-201, a sustained-release otic formulation of ciprofloxacin, in paediatric patients undergoing tympanostomy tube placement (TTP) surgery. (Source: Drug Development Technology)
Source: Drug Development Technology - August 21, 2013 Category: Pharmaceuticals Source Type: news
Certain Antibiotics Tied to Blood Sugar Swings in Diabetics
Drugs such as Cipro, Avelox were most implicated, but experts say other factors may be at play
Source: HealthDay
Related MedlinePlus Pages: Antibiotics, Blood Sugar, Diabetes (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 15, 2013 Category: Consumer Health News Source Type: news
